4.6 Article

Cutting edge:: Langerin+ dendritic cells in the mesenteric lymph node set the stage for skin and gut immune system cross-talk

期刊

JOURNAL OF IMMUNOLOGY
卷 180, 期 7, 页码 4361-4365

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.7.4361

关键词

-

资金

  1. National Research Foundation of Korea [2005-015-E00117] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Topical transcutaneous immunization (TCI) presents many clinical advantages, but its underlying mechanism remains unknown. TCI induced Ag-specific IgA Ab-secreting cells expressing CCR9 and CCR10 in the small intestine in a retinoic acid-dependent manner. These intestinal IgA Abs were maintained in Peyer's patch-null mice but abolished in the Peyer's patch- and lymph node-null mice. The mesenteric lymph node (MLN) was shown to be the site of IgA isotype class switching after M. Unexpectedly, langerin(+)CD8 alpha(-) dendritic cells emerged in the MLN after TCI; they did not migrate from the skin but rather differentiated rapidly from bone marrow precursors. Depletion of langerin(+) cells impaired intestinal IgA Ab responses after TCI. Taken together, these findings suggest that MLN is indispensable for the induction of intestinal IgA Abs following skin immunization and that cross-talk between the skin and gut immune systems might be mediated by langerin(+) dendritic cells in MLN.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism

Claude Gregoire, Lionel Spinelli, Sergio Villazala-Merino, Laurine Gil, Maria Pia Holgado, Myriam Moussa, Chuang Dong, Ana Zarubica, Mathieu Fallet, Jean-Marc Navarro, Bernard Malissen, Pierre Milpied, Mauro Gaya

Summary: This study investigated lung-resident memory B cells and identified two distinct transcriptional subsets with class switching, somatic mutation, and biased differentiation fate. The analysis of antigen specificity and B cell receptor repertoire revealed virus-specific and bystander subsets. The findings suggest that the transcriptional programs in MBCs are related to the immune system's strategies for providing protection and diversifying the B cell repertoire.

IMMUNITY (2022)

Article Allergy

Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets

Leo Laoubi, Morgane Lacoffrette, Severine Valsesia, Vanina Lenief, Aurelie Guironnet-Paquet, Amandine Mosnier, Gwendoline Dubois, Anna Cartier, Laurine Monti, Jacqueline Marvel, Eric Espinosa, Bernard Malissen, Sandrine Henri, Lucie Mondoulet, Hugh A. Sampson, Audrey Nosbaum, Jean-Francois Nicolas, Vincent Dioszeghy, Marc Vocanson

Summary: This study investigates the phenotype and functional characteristics of skin dendritic cells (skDCs) during epicutaneous immunotherapy (EPIT), finding that skDCs gradually change their phenotype and functional properties during EPIT, which is crucial for achieving desensitization.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Microbiology

Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice

Liaoxun Lu, Tianhan Li, Xinyu Feng, Zhilong Liu, Yang Liu, Tianzhu Chao, Yanrong Gu, Rong Huang, Fanghui Zhang, Le He, Binhui Zhou, Eryan Kong, Zhuangzhuang Liu, Xugang Wang, Zhijun Chen, Hui Wang, Marie Malissen, Bernard Malissen, Lichen Zhang, Yinming Liang

Summary: Schistosomiasis, a parasitic infection affecting over 200 million people worldwide, can induce the expression of PD-1 in T cells of the liver. Loss of PD-1 leads to an increase in T cell count and a shift in cytokine production in infected mice, but does not result in the eradication of parasites or reduction in pathogen burden.

PLOS PATHOGENS (2022)

Article Immunology

Selective STING stimulation in dendritic cells primes antitumor T cell responses

Bakhos Jneid, Aurore Bochnakian, Caroline Hoffmann, Fabien Delisle, Emeline Djacoto, Philemon Sirven, Jordan Denizeau, Christine Sedlik, Yohan Gerber-Ferder, Frederic Fiore, Ramazan Akyol, Carine Brousse, Robert Kramer, Ian Walters, Sylvain Carlioz, Helene Salmon, Bernard Malissen, Marc Dalod, Eliane Piaggio, Nicolas Manel

Summary: Activation of STING in immunogenic tumors can induce antitumor T cell response, but it remains unclear how to apply it in nonimmunogenic tumors. This study showed that intratumoral delivery of cGAMP-VLP activated T cells and reduced tumor regulatory T cells, synergizing with PD1 blockade. However, intratumoral administration of the synthetic CDN ADU-S100 caused tumor necrosis and systemic T cell activation, but depleted immune cells and minimally primed circulating tumor-specific T cells. Thus, cell targeting of STING stimulation shapes the antitumor T cell response and provides a strategy to enhance T cell-targeted immunotherapy.

SCIENCE IMMUNOLOGY (2023)

Article Biology

PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses

Warren Anderson, Fariba Barahmand-pour-Whitman, Peter S. Linsley, Karen Cerosaletti, Jane H. Buckner, David J. Rawlings, Bernard Malissen

Summary: A genetic variant in the PTPN22 gene increases the risk for multiple autoimmune diseases and affects T cell regulation and activation. Using gene editing, researchers created T cells with different PTPN22 variants and found that the risk variant and PTPN22 knockout both led to increased T cell activation. They also observed enhanced signaling and proliferation in T cells with self-reactive T cell receptors lacking PTPN22 function. These findings suggest that PTPN22 rs2476601 contributes to autoimmunity risk by promoting TCR signaling and activation in mildly self-reactive T cells.
Article Oncology

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Clemence Demerle, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frederic Fiore, Jacques A. Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Herve Luche, Fabrice Barlesi, Daniel Olive

Summary: The study found that anti-HVEM18-10 can enhance the activity of human αβ-T cells and trigger T cell activation in the presence of PD-L1-negative cells. Anti-HVEM18-10 treatment inhibits the growth of HVEM-positive tumors in mouse models and promotes the presence of effector memory CD4+ T cells while suppressing exhausted CD8+ T cells and regulatory T cells.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Biology

An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity

Richard Miallot, Virginie Millet, Yann Groult, Angelika Modelska, Lydie Crescence, Sandrine Roulland, Sandrine Henri, Bernard Malissen, Nicolas Brouilly, Laurence Panicot-Dubois, Renaud Vincentelli, Gerlind Sulzenbacher, Pascal Finetti, Aurelie Dutour, Jean-Yves Blay, Francois Bertucci, Franck Galland, Philippe Naquet

Summary: Aggressive tumors often have dysfunctional mitochondria. OMA1 mediates fission of mitochondria in response to oxidative stress through cleavage of the fusion effector OPA1. In this study, mutation of cysteine 403 in OMA1 impaired mitochondrial responses to stress, resulting in reduced ATP production, resistance to apoptosis, and enhanced mitochondrial DNA release. Inactivation of OMA1 increased anti-tumor immunity and may enhance sarcoma immunogenicity.

LIFE SCIENCE ALLIANCE (2023)

Article Immunology

Defective LAT signalosome pathology in mice mimics human IgG4-related disease at single-cell level

Anais Joachim, Rudy Aussel, Lena Gelard, Fanghui Zhang, Daiki Mori, Claude Gregoire, Sergio Villazala Merino, Mauro Gaya, Yinming Liang, Marie Malissen, Bernard Malissen

Summary: Mice with a loss-of-function mutation in the LAT adaptor (Lat(Y136F)) develop an autoimmune and type 2 inflammatory disorder called defective LAT signalosome pathology (DLSP). Through single-cell omics analysis, it was found that T follicular helper cells, CD4+ cytotoxic T cells, activated B cells, and plasma cells are present in Lat(Y136F) spleen and lung. This cell constellation is similar to the cell types involved in IgG4-related disease (IgG4-RD), indicating that Lat(Y136F) DLSP can serve as a model for IgG4-RD.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Biology

The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

Richard Miallot, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, Jean-Charles Martin, Laetitia Shintu, Paul Berchard, Juliane Sousa Lanza, Bernard Malissen, Sandrine Henri, Sophie Ugolini, Aurelie Dutour, Pascal Finetti, Francois Bertucci, Jean-Yves Blay, Franck Galland, Philippe Naquet

Summary: The study found that pantethine can inhibit tumor growth by enhancing the function of the immune system. Pantethine can promote the polarization of myeloid and dendritic cells towards enhanced antigen presentation pathways and improve the development of CD8+ T cells with immune effector activity. However, immune cell exhaustion limits the therapeutic effect of pantethine.

LIFE SCIENCE ALLIANCE (2023)

Meeting Abstract Oncology

Characterization of a PDX panel covering molecular diversity of non-small cell lung cancer to accelerate the development of precision therapy

Delphine Nicolle, Laura Brulle-Soumare, Katell Mevel, Ludovic Bigot, Tala Tayoun, Benjamin Besse, Francoise Farace, Luc Friboulet, Didier Decaudin, Erwan Corcuff, Anais Joachim, Bernard Malissen, Ana Zarubica, Herve Luche, Jean-Gabriel Judde, Olivier Deas

CANCER RESEARCH (2023)

Meeting Abstract Oncology

A preclinical platform of breast cancer PDX and derived cellular models as a tool for pharmacological screening and functional studies

Delphine Nicolle, Aurore Gorce, Marie Tavernier, Elisabetta Marangoni, Didier Decaudin, Christophe Ginestier, Emmanuelle Charafe-Jaufret, Judith Passildas, Nina Robin, Robert Clarke, Erwan Corcuff, Anais Joachim, Bernard Malissen, Ana Zarubica, Herve Luche, Jean-Gabriel Judde, Olivier Deas

CANCER RESEARCH (2023)

Meeting Abstract Oncology

Deep Immuno-profiling of syngeneic tumor mouse models for preclinical studies

Anais Joachim, Emilie Maturin, Marielle Mello, Lillia Hadjem, Magali Grange, Olivier Deas, Ana Zarubica, Bernard Malissen, Herve Luche

CANCER RESEARCH (2023)

Meeting Abstract Oncology

Systematic immune-profiling of immune-deficient mouse models: A rational to select ideal host for tumor implantation

Herve Luche, Lillia Hadjem, Marielle Mello, Priscilla Canavese, Fabien Angelis, Anais Joachim, Sylvie Bouilly, Frederic Guinut, Frederic Fiore, Bernard Malissen, Ana Zarubica, Erwan Corcuff

CANCER RESEARCH (2023)

Meeting Abstract Oncology

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Laurent Gorvel, Clemence Demerle, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frederic Fiore, Jacques Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Herve Luche, Fabrice Barlesi, Daniel Olive

CANCER RESEARCH (2023)

暂无数据